24 related articles for article (PubMed ID: 38321856)
1. DNA CpG methylation in sequential glioblastoma specimens.
Kraboth Z; Galik B; Tompa M; Kajtar B; Urban P; Gyenesei A; Miseta A; Kalman B
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2885-2896. PubMed ID: 32779022
[TBL] [Abstract][Full Text] [Related]
2. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
[TBL] [Abstract][Full Text] [Related]
3. The Evaluation of Glioblastoma Cell Dissociation and Its Influence on Its Behavior.
Skarkova V; Krupova M; Vitovcova B; Skarka A; Kasparova P; Krupa P; Kralova V; Rudolf E
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540507
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
Bai Y; Zhang QG; Wang XH
Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide methylation analyses in glioblastoma multiforme.
Lai RK; Chen Y; Guan X; Nousome D; Sharma C; Canoll P; Bruce J; Sloan AE; Cortes E; Vonsattel JP; Su T; Delgado-Cruzata L; Gurvich I; Santella RM; Ostrom Q; Lee A; Gregersen P; Barnholtz-Sloan J
PLoS One; 2014; 9(2):e89376. PubMed ID: 24586730
[TBL] [Abstract][Full Text] [Related]
6. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.
DeCordova S; Shastri A; Tsolaki AG; Yasmin H; Klein L; Singh SK; Kishore U
Front Immunol; 2020; 11():1402. PubMed ID: 32765498
[TBL] [Abstract][Full Text] [Related]
7. Can CpG methylation serve as surrogate markers for immune infiltration in cancer?
Bacolod MD; Barany F; Fisher PB
Adv Cancer Res; 2019; 143():351-384. PubMed ID: 31202362
[TBL] [Abstract][Full Text] [Related]
8. Tumor Cell Invasion in Glioblastoma.
Vollmann-Zwerenz A; Leidgens V; Feliciello G; Klein CA; Hau P
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32178267
[TBL] [Abstract][Full Text] [Related]
9. Monoamines in glioblastoma: complex biology with therapeutic potential.
Caragher SP; Hall RR; Ahsan R; Ahmed AU
Neuro Oncol; 2018 Jul; 20(8):1014-1025. PubMed ID: 29126252
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets.
Erices JI; Bizama C; Niechi I; Uribe D; Rosales A; Fabres K; Navarro-Martínez G; Torres Á; San Martín R; Roa JC; Quezada-Monrás C
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108208
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma epigenomics discloses a complex biology and potential therapeutic targets.
Krabóth Z; Tompa M; Urbán P; Gálik B; Kajtár B; Gyenesei A; Kálmán B
Ideggyogy Sz; 2024 Jan; 77(1-2):27-37. PubMed ID: 38321856
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]